Generated: December 15, 2017
DrugPatentWatch Database Preview
Details for Patent: 6,348,210
« Back to Dashboard
Which drugs does patent 6,348,210 protect, and when does it expire?
Patent 6,348,210 protects TESTODERM TTS and is included in one NDA.
Summary for Patent: 6,348,210
|Title:|| Methods for transdermal drug administration|
|Abstract:||Adhesive transdermal drug delivery devices may be removed and subsequently reapplied to an area of skin if the adhesive has an initial adhesive/skin bond strength sufficient to maintain said transdermal drug delivery device on the skin to which it is applied for the entire predetermined administration period; and an adhesive/skin bond strength upon replacement on the skin after removal therefrom which is adequate to retain the device on the skin for the balance of the administration period.|
|Inventor(s):|| Gale; Robert Martin (Los Altos, CA) |
|Assignee:|| Alza Corporation (Mountain View, CA) |
Patent Claim Types:|
see list of patent claims
|Use; Delivery; Device; Formulation; |
||Patented / Exclusive Use
|Alza||TESTODERM TTS||testosterone||FILM, EXTENDED RELEASE;TRANSDERMAL||020791-001||Dec 18, 1997||DISCN||No||No||► Subscribe||► Subscribe||► Subscribe||METHOD FOR TRANSDERMAL ADMINISTRATION OF A DRUG THROUGH NON-SCROTAL SKIN USING A TRANSDERMAL DRUG DELIVERY DEVICE CONTAINING THE DRUG AND HAVING AN ADHESIVE SURFACE|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.